PATENT CLAIM ANALYSIS

Application Number: 16287677
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2020-02
Patent Classification: ["null", "null"]

Abstract:
A method of preventing post-operative endophthalmitis involves injecting a colored antibiotic solution into the anterior segment of the eye during surgery, the antibiotic solution having moxifloxacin, cefuroxime, vancomycin, or some combination thereof, and the coloring agent being preferably a cobalamin (e.g., cyanocobalamin).

Claim (Index 3):
The method of  claim 2 , wherein the antibiotic solution injected into the eye comprises a range of 200 to 600 micrograms of moxifloxacin.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.30769
- Patent Class: nan
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16101828', '12167946', '15391666', '12488531', '12541744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5276750936792759
- 35 USC 102 Novelty (BERT): 0.5144113514332379
- Combined Prediction Score: 0.5263487194546721
- Mean Citation Score: 190.411866
- Max Citation Score: 330.29315
- Similarity Product: 327.5723073527009

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test